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Background 
Lung cancer screening can reduce lung cancer mortality by 20%.  It is currently recommended in the 
USA, but not in the UK and ensuring any potential psychological harm is minimised is important.  
Current evidence is limited to the psychological impact of CT lung cancer screening.  This study 
assesses psychological responses in the Early Cancer Detection Test - Lung Cancer Scotland Study (ECLS 
Study), whose participants have a tumour antibody blood test (Early CDT®-Lung test) and CT scans 
only for those with positive blood tests. 
 
Methods 
ECLS study participants were randomised to an Early CDT®-Lung test group or a control group.  A 
sample (n=1032) participated in a nested psychological outcomes study.  Questionnaires measured 
psychological responses (positive and negative affect scale (PANAS), lung cancer worry scale (LCWS) 
and impact of events scale (IES)) at baseline and 1, 3, 6 and 12 months post-trial recruitment.  
Psychological responses over time were assessed using multilevel modelling and compared between 
those in the control group, the test-positive group and the test-negative group. 
 
Results 
In total, 350, 361 and 321 participants were in the control, test-negative and test-positive groups 
respectively.  Follow-up questionnaire completion rates were ≥90% at all time-points.  Baseline 
psychological measures did not differ significantly between groups.  Significant differences were found 
between PANAS scores, but absolute differences between the groups were very small and unlikely to 
be clinically significant.  The IES avoidance and intrusion scores were significantly higher in the positive 
than the negative group at all time-points and at 1, 3 and 6 months respectively.  However, median 
scores for both subscales at all the time-points were in the subclinical range.  Anxiety about future 
tests and treatment at 1 month was significantly higher in the test-positive group than the control (OR 
(95%CI) 3.55 (1.70, 7.41) or the negative group (OR (95%CI) 5.74 (2.69, 12.2).  Worry about getting 
lung cancer in the future was significantly higher in the test-positive than the test-negative group at 1 
month (OR (95%CI) 2.61 (1.35, 5.02), 3 months (OR (95%CI) 2.52 (1.30, 4.87) and 6 months (OR (95%CI) 
2.98 (1.53, 5.82).              
         
Conclusion   
Lung cancer screening using a blood test followed by CT scanning for test-positive individuals does not 
appear to impact on affect, intrusive thoughts or avoidant behaviour to a clinically important degree.  
However, anxiety about future tests and treatment and future worry about lung cancer needs to be 
addressed if lung cancer screening is implemented in the UK.  
